GR3019416T3 - Ergoline-8-carboxamides for blocking 5HT receptors - Google Patents

Ergoline-8-carboxamides for blocking 5HT receptors

Info

Publication number
GR3019416T3
GR3019416T3 GR960400796T GR960400796T GR3019416T3 GR 3019416 T3 GR3019416 T3 GR 3019416T3 GR 960400796 T GR960400796 T GR 960400796T GR 960400796 T GR960400796 T GR 960400796T GR 3019416 T3 GR3019416 T3 GR 3019416T3
Authority
GR
Greece
Prior art keywords
receptors
blocking
carboxamides
ergoline
provides
Prior art date
Application number
GR960400796T
Other languages
English (en)
Inventor
Marlene Lois Cohen
David Wayne Robertson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3019416T3 publication Critical patent/GR3019416T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
    • H02J7/00—Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Power Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
GR960400796T 1990-04-11 1996-03-26 Ergoline-8-carboxamides for blocking 5HT receptors GR3019416T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/508,324 US5043341A (en) 1990-04-11 1990-04-11 N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides

Publications (1)

Publication Number Publication Date
GR3019416T3 true GR3019416T3 (en) 1996-06-30

Family

ID=24022297

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960400796T GR3019416T3 (en) 1990-04-11 1996-03-26 Ergoline-8-carboxamides for blocking 5HT receptors

Country Status (24)

Country Link
US (1) US5043341A (el)
EP (1) EP0452074B1 (el)
JP (1) JPH04224578A (el)
KR (1) KR0165124B1 (el)
CN (1) CN1038937C (el)
AT (1) ATE133414T1 (el)
AU (1) AU634374B2 (el)
CA (1) CA2040170A1 (el)
CZ (1) CZ279745B6 (el)
DE (1) DE69116590T2 (el)
DK (1) DK0452074T3 (el)
ES (1) ES2082923T3 (el)
FI (1) FI96604C (el)
GR (1) GR3019416T3 (el)
HU (1) HU206113B (el)
IE (1) IE72084B1 (el)
IL (1) IL97808A (el)
NO (1) NO177709C (el)
NZ (1) NZ237753A (el)
PT (1) PT97299B (el)
RU (2) RU2002746C1 (el)
TW (1) TW199859B (el)
YU (1) YU47809B (el)
ZA (1) ZA912628B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141944A (en) * 1990-04-11 1992-08-25 Eli Lilly And Company N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
JPH0613145U (ja) * 1992-07-23 1994-02-18 日新電機株式会社 基板収納カセット
US5441961A (en) * 1992-08-27 1995-08-15 Eli Lilly And Company Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines
US5599985A (en) * 1993-09-14 1997-02-04 Sepracor, Inc. Optically pure 1-amido-2-indanols
US5516943A (en) * 1993-09-14 1996-05-14 Sepracor, Inc. Process for preparing cyclic CIS-1-amino-2-alkanols
JPH11503757A (ja) * 1995-04-18 1999-03-30 イーライ・リリー・アンド・カンパニー ５−ｈｔ▲下７▼レセプターにおいて生理学的および病理学的機能を生じるエルゴリン化合物の使用方法
US5880134A (en) * 1996-03-20 1999-03-09 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
US6385208B1 (en) * 1998-06-02 2002-05-07 Cisco Technology, Inc. Serial media independent interface
HUP0400245A3 (en) * 2001-06-08 2012-09-28 Ipsen Pharma Sas Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
JP2005220081A (ja) * 2004-02-06 2005-08-18 Toray Fine Chemicals Co Ltd ｃｉｓ−４−アミノ−１−ベンジル−３−ピロリジノールの製造方法およびピロリジン誘導体
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
JP2016503402A (ja) 2012-11-01 2016-02-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエＩｐｓｅｎ Ｐｈａｒｍａ Ｓ．Ａ．Ｓ． ソマトスタチン類似体及びそのダイマー
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997470A (en) * 1956-03-05 1961-08-22 Lilly Co Eli Lysergic acid amides
US4931447A (en) * 1987-06-15 1990-06-05 Eli Lilly And Company Cycloalkylamides of (8β)-1-alkyl-6-(substituted) ergolines
MX11866A (es) * 1987-06-15 1993-12-01 Lilly Co Eli Nuevas cicloalquilamidas y procedimiento para su preparacion.

Also Published As

Publication number Publication date
YU64691A (sh) 1994-01-20
AU7433791A (en) 1991-10-17
JPH04224578A (ja) 1992-08-13
RU2002746C1 (ru) 1993-11-15
EP0452074A3 (en) 1992-03-04
NO911398L (no) 1991-10-14
NO177709B (no) 1995-07-31
CN1056496A (zh) 1991-11-27
EP0452074A2 (en) 1991-10-16
NO177709C (no) 1995-11-08
IE911205A1 (en) 1991-10-23
PT97299B (pt) 1998-08-31
DE69116590T2 (de) 1996-07-04
CA2040170A1 (en) 1991-10-12
KR910018381A (ko) 1991-11-30
FI96604C (fi) 1996-07-25
NO911398D0 (no) 1991-04-10
NZ237753A (en) 1993-02-25
FI911713A0 (fi) 1991-04-10
US5043341A (en) 1991-08-27
CN1038937C (zh) 1998-07-01
CZ99091A3 (en) 1995-03-15
CZ279745B6 (cs) 1995-06-14
DE69116590D1 (de) 1996-03-07
RU2086551C1 (ru) 1997-08-10
FI911713A (fi) 1991-10-12
FI96604B (fi) 1996-04-15
ES2082923T3 (es) 1996-04-01
IL97808A0 (en) 1992-06-21
HUT56841A (en) 1991-10-28
PT97299A (pt) 1992-01-31
EP0452074B1 (en) 1996-01-24
HU206113B (en) 1992-08-28
IE72084B1 (en) 1997-03-12
TW199859B (el) 1993-02-11
YU47809B (sr) 1996-01-09
IL97808A (en) 1994-12-29
ZA912628B (en) 1992-12-30
ATE133414T1 (de) 1996-02-15
AU634374B2 (en) 1993-02-18
KR0165124B1 (ko) 1999-03-20
DK0452074T3 (da) 1996-02-19

Similar Documents

Publication Publication Date Title
GR3019416T3 (en) Ergoline-8-carboxamides for blocking 5HT receptors
SG47026A1 (en) Serotonin antagonists
MY131298A (en) 5-heteroyl indole derivatives
SE0103648D0 (sv) Therapeutic quinolone compounds
MXPA04004073A (es) Compuestos de quinolina terapeuticos con propiedades antagonistas 5-ht.
ES2067322T3 (es) Lactamas substituidas en n utiles como antagonistas de colecistoquinina.
EA200101160A1 (ru) Монофторалкилпроизводные
HK1013958A1 (en) Treating anxiety
ATE273970T1 (de) N-acyl und n-aroyl aralkylamide
EA200000561A1 (ru) Триазиновые соединения для лечения расстройств цнс
ATE285789T1 (de) Mukosale zytotoxische t-lymphozytenantwort
ATE256255T1 (de) Grundplatte zum befestigen eines elements
EA200001105A1 (ru) 10-камфорсульфонат пароксетина для лечения нарушений цнс
DE59208052D1 (de) Schienenbefestigungsanordnung
ES2181791T3 (es) Derivados de indol para el tratamiento de la migraña.
MXPA03003926A (es) Amidas de alquinilo y sus aplicaciones terapeuticas.
SE9201162L (sv) Bullerskydd, särskilt för järnvägar och spårvägar